|

FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • SCRI Development Innovations, LLC1

Indications

  • Rectal Cancer1
  • Colorectal Cancer (CRC)1
  • Colon Cancer1
  • Colorectal Cancer1
  • Cancer1

Denver, Colorado1 trial

A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (mCRC)

Rocky Mountain Cancer Center - Primary

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.